Vaccine News and Research

Latest Vaccine News and Research

Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines

Outbreaks of norovirus in health care settings and outbreaks caused by a particular genotype of the virus are more likely to make people seriously ill, according to a new study in The Journal of Infectious Diseases.

15 Nov 2018

Researchers succeed in building protein nanotubes from tiny scaffolds

Researchers at Tokyo Institute of Technology have succeeded in constructing protein nanotubes from tiny scaffolds made by cross-linking of engineered protein crystals.

14 Nov 2018

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Scientists at the University of Liverpool have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

12 Nov 2018

Study shows how pneumococci challenge the immune system

Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis.

12 Nov 2018

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

A phase 2 clinical trial led by Stephanie N. Taylor, MD, Professor of Medicine and Microbiology in the Section of Infectious Diseases at LSU Health New Orleans School of Medicine, has found that a new antibiotic effectively treats uncomplicated urogenital and rectal gonorrhea infections in a single oral dose.

9 Nov 2018

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.

9 Nov 2018

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

In a study of proteins historic in its scope, researchers at Oregon State University have pushed closer both to a vaccine for gonorrhea and toward understanding why the bacteria that cause the disease are so good at fending off antimicrobial drugs.

8 Nov 2018

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.

8 Nov 2018

At-risk healthcare workers being vaccinated against Ebola in Uganda

Healthcare workers in Uganda have begun vaccinating high risk health workers against the deadly viral infection Ebola this week. This is the first time that a vaccination drive has begun before the actual outbreak.

7 Nov 2018

Persuading more health workers to have flu jab needs new approach

Persuading more health workers across the continent to have the flu jab to protect themselves and their patients cannot be done through facts and statistics alone, new research by a leading behavioral scientist from Kingston University in London has revealed.

7 Nov 2018

VTT, Dyadic to present data highlighting achievements in development of fungal production platform

VTT and Dyadic International, Inc., today announced that VTT scientists will present the excellent results in their collaboration over the past two years at two international conferences: AAPS PharmSci on November 7th in Washington DC and PEGS Europe on November 14th in Lisbon.

5 Nov 2018

Lymph nodes serve as reservoirs of prolonged bacterial persistence during Mtb infection

Lymph nodes can contain large numbers of tuberculosis-causing bacteria and serve as long-term reservoirs of bacterial persistence, according to a study published November 1 in the open-access journal PLOS Pathogens by JoAnne Flynn of the University of Pittsburgh School of Medicine, and colleagues.

2 Nov 2018

Wild monkeys in the Americas transmit Zika virus to humans via mosquitoes, reports study

A collaborative group of researchers from The University of Texas Medical Branch at Galveston and the Faculty of Medicine of Sao Jose do Rio in Brazil is the first to report that wild monkeys in the Americas are transmitting the Zika virus to humans via mosquitoes, making complete eradication of the virus in the Americas very unlikely.

2 Nov 2018

Rubella eliminated from Australia confirms WHO

The World Health Organization (WHO) has confirmed that Australia has managed to eliminate the viral infection rubella from its population. This is a significant achievement on part of the country’s healthcare system. WHO defines elimination of a disease as “reduction to zero of the incidence of infection caused by a specific agent in a defined geographical area”.

2 Nov 2018

Measles can be deadly for people with weakened immune systems

Last year, a 26-year-old man receiving treatment for leukemia went to a Swiss hospital's emergency room with a fever, a sore throat, and a cough, and was admitted. His condition worsened, and 17 days later, he died from severe complications of measles.

1 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

New study to evaluate human immune system's response to influenza

The key to lasting protection against influenza may be in your bones. The cells that naturally protect you against illness originate and live in your bone marrow - and that is one spot where scientists will be looking to understand the human immune system's response to influenza in a groundbreaking new study led by the Human Vaccines Project.

1 Nov 2018

World’s first vaccine against coeliac disease to be tested in Australia

US-based pharmaceutical company ImmusanT, after worldwide trials, is all set to start clinical trials of a new vaccine against coeliac disease at the Royal Melbourne Hospital Clinical Trials Centre in Melbourne. This will be followed by trials to be held at Adelaide, Brisbane, Perth, Mackay and Sunshine Coast say the sources.

31 Oct 2018

Monkeys infected with Zika virus points to a sylvatic transmission cycle

Zika virus has been detected in dead monkeys found in Brazil near São José do Rio Preto, São Paulo State, and Belo Horizonte, Minas Gerais.

30 Oct 2018

Study reveals how Seneca Valley Virus interacts with tumor receptors

Seneca Valley Virus sounds like the last bug you’d want to catch, but it could be the next breakthrough cancer therapy.

30 Oct 2018

Vaccine News and Research

Latest Vaccine News and Research

Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines

Researchers succeed in building protein nanotubes from tiny scaffolds

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Study shows how pneumococci challenge the immune system

New single-dose antibiotic effectively treats uncomplicated gonorrhea infections

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

At-risk healthcare workers being vaccinated against Ebola in Uganda

Persuading more health workers to have flu jab needs new approach

VTT, Dyadic to present data highlighting achievements in development of fungal production platform

Lymph nodes serve as reservoirs of prolonged bacterial persistence during Mtb infection

Wild monkeys in the Americas transmit Zika virus to humans via mosquitoes, reports study

Rubella eliminated from Australia confirms WHO

Measles can be deadly for people with weakened immune systems

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

New study to evaluate human immune system's response to influenza

World’s first vaccine against coeliac disease to be tested in Australia

Monkeys infected with Zika virus points to a sylvatic transmission cycle

Study reveals how Seneca Valley Virus interacts with tumor receptors

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in